Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Genotype-Guided Dosing Study of FOLFIRABRAX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02333188
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:08.336080+00:00
Published At
2023-05-31T00:00:00+00:00
Record Updated At
2023-05-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adenocarcinoma of Unknown Primary", "Adult Cholangiocarcinoma", "Gallbladder Carcinoma", "Gastric Adenocarcinoma", "Malignant Gastrointestinal Neoplasm", "Metastatic Pancreatic Adenocarcinoma", "Pancreatic Adenocarcinoma", "Stage III Ampulla of Vater Cancer", "Stage III Pancreatic Cancer", "Stage IIIA Gallbladder Cancer", "Stage IIIA Gastric Cancer", "Stage IIIB Gallbladder Cancer", "Stage IIIB Gastric Cancer", "Stage IV Ampulla of Vater Cancer", "Stage IV Gallbladder Cancer", "Stage IV Gastric Cancer", "Stage IV Pancreatic Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-31"
protocolSection.identificationModule.nctId
"NCT02333188"
protocolSection.identificationModule.officialTitle
"A Genotype-Guided Dosing Study of FOLFIRABRAX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adenocarcinoma of Unknown Primary (protocolSection.conditionsModule.conditions)
  • Adult Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Gastric Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Malignant Gastrointestinal Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Ampulla of Vater Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Ampulla of Vater Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Gallbladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.